Phase 3 Safety Study of LNZ100 and LNZ101 for the Treatment of Presbyopia Subjects
Public ClinicalTrials.gov record NCT05753189. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety Study: A Multi-Center, Double-Masked Phase 3 Safety Study Evaluation of the Long-Term Safety of LNZ101 in Presbyopic Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Safety Study of the Long-Term Safety of LNZ100 \& LNZ101 in Presbyopic Subjects
Study identification
- NCT ID
- NCT05753189
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 362 participants
Conditions and interventions
Conditions
Interventions
- Aceclidine+Brimonidine combination ophthalmic solution Drug
- Aceclidine ophthalmic solution Drug
- Vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 45 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 21, 2023 (Actual)
- Primary completion
- Feb 9, 2024 (Actual)
- Completion
- Feb 9, 2024 (Actual)
- Last update posted
- May 13, 2026
2023 – 2024
United States locations
- U.S. sites
- 40
- U.S. states
- 20
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site #326 | Dothan | Alabama | 36301 | — |
| Site #302 | Chandler | Arizona | 85224 | — |
| Site #320 | Mesa | Arizona | 85202 | — |
| Site #321 | Phoenix | Arizona | 85032 | — |
| Site #328 | Phoenix | Arizona | 85053 | — |
| Site #338 | Scottsdale | Arizona | 85260 | — |
| Site #331 | Sun City | Arizona | 85351 | — |
| Site #303 | Garden Grove | California | 92843 | — |
| Site #313 | Glendale | California | 91204 | — |
| Site #334 | La Jolla | California | 92037 | — |
| Site #322 | Newport Beach | California | 92663 | — |
| Site #306 | Petaluma | California | 94954 | — |
| Site #337 | Rancho Cordova | California | 95670 | — |
| Site #304 | Santa Barbara | California | 93105 | — |
| Site #308 | Littleton | Colorado | 80120 | — |
| Site #316 | Danbury | Connecticut | 06810 | — |
| Site #319 | Crystal River | Florida | 34429 | — |
| Site #309 | Mt. Dora | Florida | 32757 | — |
| Site #339 | Morrow | Georgia | 30260 | — |
| Site #340 | Northbrook | Illinois | 60062 | — |
| Site #317 | Rock Island | Illinois | 61201 | — |
| Site #301 | Overland Park | Kansas | 66210 | — |
| Site #307 | Pittsburg | Kansas | 66762 | — |
| Site #324 | Louisville | Kentucky | 40206 | — |
| Site #336 | Alexandria | Minnesota | 56308 | — |
| Site #330 | Kansas City | Missouri | 64154 | — |
| Site #325 | St Louis | Missouri | 63128 | — |
| Site #335 | Bozeman | Montana | 59718 | — |
| Site #341 | Dover | New Jersey | 07801 | — |
| Site #310 | Fargo | North Dakota | 58103 | — |
| Site #332 | West Fargo | North Dakota | 58078 | — |
| Site #329 | Cincinnati | Ohio | 45242 | — |
| Site #323 | Powell | Ohio | 43065 | — |
| Site #333 | Eugene | Oregon | 97401 | — |
| Site #312 | Cranberry Township | Pennsylvania | 16066 | — |
| Site #315 | Memphis | Tennessee | 38104 | — |
| Site #311 | Smyrna | Tennessee | 37167 | — |
| Site #314 | El Paso | Texas | 79902 | — |
| Site #318 | San Antonio | Texas | 78229 | — |
| Site #327 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05753189, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05753189 live on ClinicalTrials.gov.